These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8534428)

  • 1. Intracellular and surface distribution of CD9 in human eosinophils.
    Fernvik E; Halldén G; Hed J; Lundahl J
    APMIS; 1995 Oct; 103(10):699-706. PubMed ID: 8534428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of in vitro activation and platelet interaction on the CD9 distribution and adhesion properties of human eosinophils.
    Fernvik E; Lundahl J; Magnusson CG; Halldén G
    Inflamm Res; 1999 Jan; 48(1):28-35. PubMed ID: 9987680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-localization of CD9 and GPIIb-IIIa (alpha IIb beta 3 integrin) on activated platelet pseudopods and alpha-granule membranes.
    Brisson C; Azorsa DO; Jennings LK; Moog S; Cazenave JP; Lanza F
    Histochem J; 1997 Feb; 29(2):153-65. PubMed ID: 9147072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the dual effects on platelets of a monoclonal antibody to CD9, and on the properties of platelet CD9.
    Inngjerdingen M; Waterhouse K; Solum NO
    Thromb Res; 1999 Sep; 95(5):215-27. PubMed ID: 10515286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activation of human platelets mediated by two monoclonal antibodies raised against CD9.
    Peng L; Li JZ; Wu HZ; Wang MJ
    Thromb Res; 1997 Jul; 87(1):65-73. PubMed ID: 9253801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microparticle generation during in vitro platelet activation by anti-CD9 murine monoclonal antibodies.
    Nomura S; Nagata H; Suzuki M; Kondo K; Ohga S; Kawakatsu T; Kido H; Fukuori T; Yamaguchi K; Iwata K
    Thromb Res; 1991 Jun; 62(5):429-39. PubMed ID: 1896962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditions in blood sampling procedures that extend the ex vivo stability of eosinophil activity markers in peripheral blood from allergic patients and healthy controls.
    Halldén G; Nopp A; Ihre E; Peterson C; Lundahl J
    Ann Allergy Asthma Immunol; 1999 Nov; 83(5):413-21. PubMed ID: 10582722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of rat NCA/CD9 cell surface antigen and its expression by normal and malignant neural cells.
    Deissler H; Blass-Kampmann S; Kindler-Röhrborn A; Meyer HE; Rajewsky MF
    J Neurosci Res; 1996 Mar; 43(6):664-74. PubMed ID: 8984196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A CD9, alphaIIbbeta3, integrin-associated protein, and GPIb/V/IX complex on the surface of human platelets is influenced by alphaIIbbeta3 conformational states.
    Longhurst CM; White MM; Wilkinson DA; Jennings LK
    Eur J Biochem; 1999 Jul; 263(1):104-11. PubMed ID: 10429193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of CD9 molecules in survival and activation of human eosinophils.
    Kim JT; Gleich GJ; Kita H
    J Immunol; 1997 Jul; 159(2):926-33. PubMed ID: 9218613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetraspanin CD9 is required for microparticle release from coated-platelets.
    Dale GL; Remenyi G; Friese P
    Platelets; 2009 Sep; 20(6):361-6. PubMed ID: 19658001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet p24/CD9, a member of the tetraspanin family of proteins.
    Jennings LK; Crossno JT; Fox CF; White MM; Green CA
    Ann N Y Acad Sci; 1994 Apr; 714():175-84. PubMed ID: 8017766
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet activation by CD9 monoclonal antibodies is mediated by the Fc gamma II receptor.
    Worthington RE; Carroll RC; Boucheix C
    Br J Haematol; 1990 Feb; 74(2):216-22. PubMed ID: 2317457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic eosinophils express IL-2R chains alpha and beta and co-stimulatory molecules CD28 and CD86.
    Seton K; Håkansson L; Carlson M; Stålenheim G; Venge P
    Respir Med; 2003 Aug; 97(8):893-902. PubMed ID: 12924515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functional cell surface glycoprotein CD9 is distinguished by being the major fatty acid acylated and a major iodinated cell-surface component of the human platelet.
    Seehafer JG; Slupsky JR; Tang SC; Shaw AR
    Biochim Biophys Acta; 1988 Jan; 952(1):92-100. PubMed ID: 3275469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the tetraspanin CD9-integrin alphaIIbbeta3 (GPIIb-IIIa) complex in platelet membranes and transfected cells.
    Indig FE; Diaz-Gonzalez F; Ginsberg MH
    Biochem J; 1997 Oct; 327 ( Pt 1)(Pt 1):291-8. PubMed ID: 9355765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD9 antigen on normal activated human B cells.
    Zeleznik-Le NJ; Metzgar RS
    Cell Immunol; 1989 Oct; 123(1):70-82. PubMed ID: 2673548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet tetraspanin complexes and their association with lipid rafts.
    Israels SJ; McMillan-Ward EM
    Thromb Haemost; 2007 Nov; 98(5):1081-7. PubMed ID: 18000614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulus-response coupling in human platelets activated by monoclonal antibodies to the CD9 antigen, a 24 kDa surface-membrane glycoprotein.
    Carroll RC; Worthington RE; Boucheix C
    Biochem J; 1990 Mar; 266(2):527-35. PubMed ID: 2317202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD63 associates with the alphaIIb beta3 integrin-CD9 complex on the surface of activated platelets.
    Israels SJ; McMillan-Ward EM; Easton J; Robertson C; McNicol A
    Thromb Haemost; 2001 Jan; 85(1):134-41. PubMed ID: 11204565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.